Carbidopa Monohydrate is a pharmaceutical compound used as an active pharmaceutical ingredient in combination with levodopa for the management of symptoms associated with Parkinson's disease. It is supplied as a hydrate, salt-like form with specific stereochemistry, and is characterized by its aromatic ring and polar functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Carbidopa Monohydrate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Cessna LC-126
pharmaceutical raw material
(S)-(−)-carbidopa
pharmaceutical raw material
(+)-1-phenethylamine
pharmaceutical raw material
Sodium N-sulfoglucosamine
pharmaceutical raw material
Nalidixic acid
pharmaceutical raw material
Somatostatin
pharmaceutical raw material
The international HS code for Carbidopa Monohydrate (CAS 38821-49-7) is 2928.00.
2928.00
2928 00 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid;hydrate
QTAOMKOIBXZKND-PPHPATTJSA-N
C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.O
Sourcing Carbidopa Monohydrate?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.